These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29371957)

  • 1. Anti-Müllerian hormone levels in patients with gestational trophoblastic neoplasia treated with different chemotherapy regimens: a prospective cohort study.
    Bi X; Zhang J; Cao D; Sun H; Feng F; Wan X; Xiang Y; Qiu L; Cheng X; Yang J; Shen K
    Oncotarget; 2017 Dec; 8(69):113920-113927. PubMed ID: 29371957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective cohort study with serum anti-mullerian hormone levels change in patients undergoing uterine preservation after gestational trophoblastic neoplasia treatment with a methotrexate regimen.
    Tuan Dat D; Huyen Thuong PT; Hong Hai D; Khac Toan N; Tai Duc N; Duy Anh N; Thi Thu Ha N
    Clin Ter; 2024; 175(2):128-134. PubMed ID: 38571471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Müllerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia.
    Iwase A; Sugita A; Hirokawa W; Goto M; Yamamoto E; Takikawa S; Nakahara T; Nakamura T; Kondo M; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2013 Apr; 167(2):194-8. PubMed ID: 23274042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Chemotherapy on the Levels of Serum Anti-Müllerian Hormone in Patients with Gestational Trophoblastic Neoplasia.
    Zamani M; Mohsenpour F; Torkzaban F; Atrvash N; Majlesi A; Torkzaban A
    J Reprod Infertil; 2023; 24(1):43-48. PubMed ID: 36919051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
    Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
    Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of serum anti-Müllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer.
    Dezellus A; Barriere P; Campone M; Lemanski C; Vanlemmens L; Mignot L; Delozier T; Levy C; Bendavid C; Debled M; Bachelot T; Jouannaud C; Loustalot C; Mouret-Reynier MA; Gallais-Umbert A; Masson D; Freour T
    Eur J Cancer; 2017 Jul; 79():72-80. PubMed ID: 28463758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian Hormone in Patients Treated with Chemotherapy for Gestational Trophoblastic Neoplasia Does Not Predict Short-Term Fertility.
    Ghorani E; Ramaswami R; Smith RJ; Savage PM; Seckl MJ
    J Reprod Med; 2016; 61(5-6):205-9. PubMed ID: 27424359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.
    Barbakadze L; Kristesashvili J; Khonelidze N; Tsagareishvili G
    Int J Fertil Steril; 2015; 8(4):393-8. PubMed ID: 25780521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the multiples of the median of serum anti-müllerian hormone and pregnancy outcomes in patients with gestational trophoblastic disease: A case-control study.
    Lai THT; Lau LSK; Ngu SF; Chu MYM; Chan KKL; Ng EHY; Ngan HYS; Li RHW; Tse KY
    Cancer Med; 2024 Apr; 13(7):e7134. PubMed ID: 38545760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia.
    Xue W; Cang W; Zhao J; Feng F; Wan X; Ren T; Qiu L; Yang J; Xiang Y
    Int J Gynecol Cancer; 2023 Aug; 33(8):1222-1226. PubMed ID: 37290904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
    Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
    Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy.
    Lee DY; Park YH; Lee JE; Choi D
    Breast Cancer Res Treat; 2018 Oct; 171(3):649-656. PubMed ID: 29943121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone serum values and ovarian reserve: can it predict a decrease in fertility after ovarian stimulation by ART cycles?
    Patrelli TS; Gizzo S; Sianesi N; Levati L; Pezzuto A; Ferrari B; Bacchi Modena A
    PLoS One; 2012; 7(9):e44571. PubMed ID: 22984527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study.
    Yuan H; Wang C; Wang D; Wang Y
    J Minim Invasive Gynecol; 2015; 22(4):637-41. PubMed ID: 25653041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.
    Raeissi A; Torki A; Moradi A; Mousavipoor SM; Pirani MD
    Int J Fertil Steril; 2015; 9(1):27-32. PubMed ID: 25918589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of chemotherapy on ovarian function and quality of life of patients with gestational trophoblastic neoplasia].
    Xue W; Yang JJ; Zhao J; Ren T; Feng FZ; Wan XR; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):377-383. PubMed ID: 29961279
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
    Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
    BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China.
    Wang S; Pei L; Hu T; Jia M; Wang S
    Hum Reprod; 2021 Mar; 36(4):976-986. PubMed ID: 33411897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.